Protagenic Therapeutics News

S-1: General form for registration of securities under the Securities Act of 1933

Dec 20 06:15 ET

PRE 14A: Preliminary proxy statements relating to merger or acquisition

Dec 19 06:29 ET

8-K: Current report

Dec 3 07:21 ET

8-K: Current report

Nov 22 16:17 ET

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(5.10%),Steven Boyd(5.10%)

Nov 14 17:22 ET

10-Q: Q3 2024 Earnings Report

Nov 14 16:28 ET

8-K: Current report

Nov 5 07:41 ET

8-K: Current report

Oct 30 06:07 ET

8-K: Current report

Sep 18 06:02 ET

10-Q: Q2 2024 Earnings Report

Aug 14 17:01 ET

8-K: Current report

Jul 26 17:34 ET

S-3: Registration statement for specified transactions by certain issuers

Jun 14 17:35 ET

8-K: Current report

May 24 16:41 ET

8-K: Current report

May 22 09:19 ET

10-Q: Q1 2024 Earnings Report

May 15 16:44 ET

10-K/A: Annual report (Amendment)

May 14 06:09 ET

10-K/A: Annual report (Amendment)

Apr 24 12:47 ET

Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WRIGHT TIMOTHY R

Apr 1 21:43 ET

Protagenic Therapeutics | 10-K: FY2023 Annual Report

Apr 1 16:03 ET

Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Stein Robert Benjamin

Mar 29 21:33 ET